6Z45

CDK9-Cyclin-T1 complex bound by compound 24

Summary for 6Z45

• Entry DOI: 10.2210/pdb6z45/pdb
• Descriptor: Cyclin-dependent kinase 9, Cyclin-T1, (1~{S},3~{R})-3-acetamido-~{N}-[5-chloranyl-4-(5,5-dimethyl-4,6-dihydropyrrolo[1,2-b]pyrazol-3-yl)pyridin-2-yl]cyclohexane-1-carboxamide, ... (5 entities in total)
• Functional Keywords: inhibitor, complex, kinase, transferase
• Biological source: Homo sapiens (Human); More
• Total number of polymer chains: 2
• Total formula weight: 68597.23

Authors

Ferguson, A.,Collie, G.W. (deposition date: 2020-05-22, release date: 2020-12-23, Last modification date: 2021-01-06)

• Primary citation: Barlaam, B.,Casella, R.,Cidado, J.,Cook, C.,De Savi, C.,Dishington, A.,Donald, C.S.,Drew, L.,Ferguson, A.D.,Ferguson, D.,Glossop, S.,Grebe, T.,Gu, C.,Hande, S.,Hawkins, J.,Hird, A.W.,Holmes, J.,Horstick, J.,Jiang, Y.,Lamb, M.L.,McGuire, T.M.,Moore, J.E.,O'Connell, N.,Pike, A.,Pike, K.G.,Proia, T.,Roberts, B.,San Martin, M.,Sarkar, U.,Shao, W.,Stead, D.,Sumner, N.,Thakur, K.,Vasbinder, M.M.,Varnes, J.G.,Wang, J.,Wang, L.,Wu, D.,Wu, L.,Yang, B.,Yao, T.; Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies.; J.Med.Chem., 63:15564-15590, 2020; PubMed: 33306391; DOI: 10.1021/acs.jmedchem.0c01754

Experimental method

X-RAY DIFFRACTION (3.37 Å)